Clinical Trial Update: The Efficacy and Safety of PEG-rhG-CSF in Neutropenia After Chemotherapy [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating the efficacy and safety of PEG-rhG-CSF for neutropenia after chemotherapy in patients with breast cancer, lymphoma, bon…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bone Cancer
• Breast Cancer
• Gynecologic Cancer
• Lymphoma

Drugs mentioned

• PEG-rhG-CSF (pegylated recombinant human granulocyte colony-stimulating factor)

Snippet

Sponsor: Peking University | Conditions: Mammary Cancer, Lymphoma | Phase 4 | Status: UNKNOWN